Daily News

Drug Price Debate May Target Supply Chain Middlemen In 2018

January 03, 2018
How to curb drug price increases is expected to remain a topic of debate in 2018, though the policies with the most support among lawmakers and administration officials target pharmacy benefit managers instead of drug makers. At least one more congressional hearing on the topic is expected in 2018, states are asking CMS to allow closed formularies in Medicaid, the agency is considering testing value-based reimbursement approaches and the Federal Trade Commission is looking into what causes drug price hikes...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.